↓ Skip to main content

Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion

Overview of attention for article published in Clinical Materials, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
patent
1 patent

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion
Published in
Clinical Materials, August 2014
DOI 10.1016/j.biomaterials.2014.07.016
Pubmed ID
Authors

Arun H.S. Kumar, Kenneth Martin, Brendan Doyle, Chien-Ling Huang, Gopala-Krishnan M. Pillai, Mohammed T. Ali, Kimberly A. Skelding, Shaohua Wang, Birgitta M. Gleeson, Saleem Jahangeer, Erik L. Ritman, Stephen J. Russell, Noel M. Caplice

Abstract

Site specific targeting remains elusive for gene and stem cell therapies in the cardiovascular field. One promising option involves use of devices that deliver larger and more sustained cell/gene payloads to specific disease sites using the versatility of percutaneous vascular access technology. Smooth muscle cells (SMCs) engineered to deliver high local concentrations of an angiogenic molecule (VEGF) were placed in an intravascular cell delivery device (ICDD) in a porcine model of chronic total occlusion (CTO) involving ameroid placement on the proximal left circumflex (LCx) artery. Implanted SMC were retained within the ICDD and were competent for VEGF production in vitro and in vivo. Following implantation, micro-CT analyses revealed that ICDD-VEGF significantly enhanced vasa vasora microvessel density with a concomitant increase in tissue VEGF protein levels and formation of endothelial cell colonies suggesting increased angiogenic potential. ICDD-VEGF markedly enhanced regional blood flow determined by microsphere and contrast CT analysis translating to a functional improvement in regional wall motion and global left ventricular (LV) systolic and diastolic function. Our data indicate robust, clinically relevant angiogenesis can be achieved in a human scale porcine chronic vascular occlusion model following ICDD-VEGF-based delivery of angiogenic cells. This may have implications for percutaneous delivery of numerous therapeutic factors promoting creation of microvascular bypass networks in chronic vaso-occlusive diseases.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 21%
Student > Bachelor 5 15%
Student > Postgraduate 4 12%
Researcher 4 12%
Student > Ph. D. Student 4 12%
Other 5 15%
Unknown 5 15%
Readers by discipline Count As %
Medicine and Dentistry 9 26%
Engineering 4 12%
Biochemistry, Genetics and Molecular Biology 3 9%
Sports and Recreations 3 9%
Agricultural and Biological Sciences 2 6%
Other 7 21%
Unknown 6 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2023.
All research outputs
#2,420,007
of 25,394,764 outputs
Outputs from Clinical Materials
#515
of 10,758 outputs
Outputs of similar age
#23,757
of 241,203 outputs
Outputs of similar age from Clinical Materials
#7
of 108 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,758 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,203 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.